Biogen Stock Slips As Alzheimer’s Drug Looks Abroad For Quarterly Beat
Investor's Business DailyBiogen stock slipped early Thursday despite a second-quarter beat that included strong of its new Alzheimer’s treatment, Leqembi.
The post Biogen Stock Slips As Alzheimer's Drug Looks Abroad For Quarterly Beat appeared first on Investor's Bus…